These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31174481)

  • 1. Clustering of leprosy beyond the household level in a highly endemic setting on the Comoros, an observational study.
    Ortuno-Gutierrez N; Baco A; Braet S; Younoussa A; Mzembaba A; Salim Z; Amidy M; Grillone S; de Jong BC; Richardus JH; Hasker E
    BMC Infect Dis; 2019 Jun; 19(1):501. PubMed ID: 31174481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
    Ortuno-Gutierrez N; Younoussa A; Randrianantoandro A; Braet S; Cauchoix B; Ramboarina S; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Richardus JH; de Jong BC; Hasker E
    BMC Infect Dis; 2019 Dec; 19(1):1033. PubMed ID: 31805862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing leprosy with retrospective active case finding combined with single-dose rifampicin for contacts in a low endemic setting: results of the Leprosy Post-Exposure Prophylaxis program in Cambodia.
    Cavaliero A; Ay SS; Aerts A; Lay S; So V; Robijn J; Steinmann P
    Acta Trop; 2021 Dec; 224():106138. PubMed ID: 34562427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
    Smith WC; Aerts A
    Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring clustering of leprosy in the Comoros and Madagascar: A geospatial analysis.
    Ortuño-Gutiérrez N; Mzembaba A; Ramboarina S; Andriamira R; Baco A; Braet S; Younoussa A; Cauchoix B; Salim Z; Amidy M; Grillone S; Rasamoelina T; Cambau E; Geluk A; de Jong BC; Richardus JH; Hasker E
    Int J Infect Dis; 2021 Jul; 108():96-101. PubMed ID: 33991682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
    Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
    Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.
    Tiwari A; Dandel S; Djupuri R; Mieras L; Richardus JH
    BMC Infect Dis; 2018 Jul; 18(1):324. PubMed ID: 29996781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
    Marijke Braet S; Jouet A; Aubry A; Van Dyck-Lippens M; Lenoir E; Assoumani Y; Baco A; Mzembaba A; Cambau E; Vasconcellos SEG; Rigouts L; Suffys PN; Hasker E; Supply P; de Jong BC
    Lancet Microbe; 2022 Sep; 3(9):e693-e700. PubMed ID: 35850123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
    Mieras L; Anthony R; van Brakel W; Bratschi MW; van den Broek J; Cambau E; Cavaliero A; Kasang C; Perera G; Reichman L; Richardus JH; Saunderson P; Steinmann P; Yew WW
    Infect Dis Poverty; 2016 Jun; 5(1):46. PubMed ID: 27268059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique and Tanzania.
    Schoenmakers A; Hambridge T; van Wijk R; Kasang C; Richardus JH; Bobosha K; Mitano F; Mshana SE; Mamo E; Marega A; Mwageni N; Letta T; Muloliwa AM; Kamara DV; Eman AM; Raimundo L; Njako B; Mieras L
    BMJ Open; 2021 Aug; 11(8):e046125. PubMed ID: 34446483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
    Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
    Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
    Barth-Jaeggi T; Steinmann P; Mieras L; van Brakel W; Richardus JH; Tiwari A; Bratschi M; Cavaliero A; Vander Plaetse B; Mirza F; Aerts A;
    BMJ Open; 2016 Nov; 6(11):e013633. PubMed ID: 27856484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leprosy post-exposure prophylaxis in the Indian health system: A cost-effectiveness analysis.
    Tiwari A; Blok DJ; Arif M; Richardus JH
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008521. PubMed ID: 32750059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
    Richardus JH; Tiwari A; Barth-Jaeggi T; Arif MA; Banstola NL; Baskota R; Blaney D; Blok DJ; Bonenberger M; Budiawan T; Cavaliero A; Gani Z; Greter H; Ignotti E; Kamara DV; Kasang C; Manglani PR; Mieras L; Njako BF; Pakasi T; Pandey BD; Saunderson P; Singh R; Smith WCS; Stäheli R; Suriyarachchi ND; Tin Maung A; Shwe T; van Berkel J; van Brakel WH; Vander Plaetse B; Virmond M; Wijesinghe MSD; Aerts A; Steinmann P
    Lancet Glob Health; 2021 Jan; 9(1):e81-e90. PubMed ID: 33129378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.
    Mieras LF; Taal AT; van Brakel WH; Cambau E; Saunderson PR; Smith WCS; Prakoeswa CRS; Astari L; Scollard DM; do Nascimento DC; Grosset J; Kar HK; Izumi S; Gillini L; Virmond MCL; Sturkenboom MGG
    BMC Infect Dis; 2018 Oct; 18(1):506. PubMed ID: 30290790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
    Idema WJ; Majer IM; Pahan D; Oskam L; Polinder S; Richardus JH
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e874. PubMed ID: 21072235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
    Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
    Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the impact of household contact and mass chemoprophylaxis on future new leprosy cases in South Tarawa, Kiribati: A modelling study.
    Gilkison C; Chambers S; Blok DJ; Richardus JH; Timeon E; Rimon E; Priest P
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007646. PubMed ID: 31539374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy chemoprophylaxis of household contacts: A survey of Canadian infectious disease and tropical medicine specialists.
    Boodman C; Keystone J; Bogoch II
    J Assoc Med Microbiol Infect Dis Can; 2022 Mar; 7(1):8-13. PubMed ID: 36340847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation approaches for leprosy prevention with single-dose rifampicin: A support tool for decision making.
    Ter Ellen F; Tielens K; Fenenga C; Mieras L; Schoenmakers A; Arif MA; Veldhuijzen N; Peters R; Ignotti E; Kasang C; Quao B; Steinmann P; Banstola NL; Oraga J; Budiawan T
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010792. PubMed ID: 36251696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.